Definium Therapeutics (DFTX) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T17:01:58.189Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:01:58.189Z.

Quote observation: 2026-10-06T17:00:45.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: N/A
Quote market capitalization: 4,663,270,513
Total debt · period ending 2026-06-30: 36,467,000
Cash · period ending 2026-06-30: 655,267,000

FMP input reference: 3e31615b66e5acc6c2b7b3f8a521ec69124b31f47383f0f9627e8176a83f275d

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

DFTX EBITDA Yield Metrics

EBITDA YIELD

N/A

DFTX Competitors' EBITDA Yield

DFTX

Definium Therapeutics, Inc.

Current

Market Cap

$4.66B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPCH

Option Care Health, Inc.

vs DFTX

Market Cap

$4.66B

EBITDA Yield

7.15%

TTM Avg

7.73%

3Y Avg

6.77%

5Y Avg

5.88%

LFST

LifeStance Health Group, Inc.

vs DFTX

Market Cap

$4.67B

EBITDA Yield

2.86%

TTM Avg

2.61%

3Y Avg

2.07%

5Y Avg

1.96%

BLLN

BillionToOne, Inc.

vs DFTX

Market Cap

$4.62B

EBITDA Yield

1.32%

TTM Avg

0.79%

3Y Avg

0.79%

5Y Avg

0.79%

DNTH

Dianthus Therapeutics, Inc.

vs DFTX

Market Cap

$4.71B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORKA

Oruka Therapeutics, Inc.

vs DFTX

Market Cap

$4.82B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRM

Mirum Pharmaceuticals, Inc.

vs DFTX

Market Cap

$4.85B

EBITDA Yield

N/A

TTM Avg

0.05%

3Y Avg

0.05%

5Y Avg

0.05%

HTFL

Heartflow, Inc. Common Stock

vs DFTX

Market Cap

$4.43B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADPT

Adaptive Biotechnologies Corporation

vs DFTX

Market Cap

$4.41B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INDV

Indivior Pharmaceuticals Inc

vs DFTX

Market Cap

$4.40B

EBITDA Yield

11.37%

TTM Avg

8.95%

3Y Avg

6.39%

5Y Avg

6.78%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Definium Therapeutics, Inc. (DFTX)	$4.66B	N/A	N/A	N/A	N/A
Option Care Health, Inc. (OPCH)vs ›	$4.66B	7.15%	7.73%	6.77%	5.88%
LifeStance Health Group, Inc. (LFST)vs ›	$4.67B	2.86%	2.61%	2.07%	1.96%
BillionToOne, Inc. (BLLN)vs ›	$4.62B	1.32%	0.79%	0.79%	0.79%
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.71B	N/A	N/A	N/A	N/A
Oruka Therapeutics, Inc. (ORKA)vs ›	$4.82B	N/A	N/A	N/A	N/A
Mirum Pharmaceuticals, Inc. (MIRM)vs ›	$4.85B	N/A	0.05%	0.05%	0.05%
Heartflow, Inc. Common Stock (HTFL)vs ›	$4.43B	N/A	N/A	N/A	N/A
Adaptive Biotechnologies Corporation (ADPT)vs ›	$4.41B	N/A	N/A	N/A	N/A
Indivior Pharmaceuticals Inc (INDV)vs ›	$4.40B	11.37%	8.95%	6.39%	6.78%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

DFTX EBITDA Yield Metrics

DFTX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics